DIM — Sartorius Stedim Biotech SA Share News
0.000.00%
- €21.72bn
- €23.90bn
- €2.97bn
Sartorius, Sartorius Stedim Biotech jump after Q4 earnings beat
Brief: Sartorius Stedim Biotech Prelim. FY Underlying EBITDA At EUR 779 Mln
Brief: Sartorius Michael Grosse To Become CEO
Sartorius rises as Bioprocessing orders boost 9M results
Brief: Sartorius Confirms FY Outlook
RBC ups Sartorius, Stedim Biotech as shares underperformance provides an opportunity
Europe Research Roundup: Draegerwerk, Hikma, Novartis
Tecan's guidance cut dents peers Sartorius, Stedim Biotech shares
Top of the Street: Eni, Sartorius Stedim Biotech, Sartorius
Bernstein starts Sartorius, unit Stedim with 'underperform' on 2028 outlook risks
Europe Research Roundup: Greencore, UCB, Unilever
Sartorius jumps as peer Danaher posts Q2 profit beat
Sartorius slips in early trade after guidance cut
Sartorius cuts annual profit margin outlook on lower lab equipment demand (updated)
Sartorius cuts annual profit margin outlook on lower lab equipment demand
Brief: Sartorius Sees Sales Revenue Is Now Forecast To Be Around 12 % In 2024
Brief: Sartorius cuts full year guidance and reports H1 results
Brief: Sartorius Stedim Says Confirmed Forecast For 2024 & Medium-Term Ambition Till 2028.
Brief: Sartorius, NVIDIA To Collaborate On Drug Discovery And Manufacturing Using AI